The Journal of Urology
Volume 178, Issue 6 , Pages 2383-2384, December 2007

Editorial Comments

  • David I. Quinn

      Affiliations

    • Section of Genitourinary Oncology, Division of Cancer Medicine and Blood Diseases
    • ,
  • Kenneth J. Norris Jr.

      Affiliations

    • Comprehensive Cancer Center, University of Southern California, Los Angeles, California

published online 15 October 2007.

No abstract is available. To read the body of this article, please view the Full Text online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0022-5347(07)02369-5

doi:10.1016/j.juro.2007.08.196

Refers to article:

  • A Phase II Trial of Bortezomib and Prednisone for Castration Resistant Metastatic Prostate Cancer , 15 October 2007

    Michael J. Morris, W. Kevin Kelly, Susan Slovin, Charles Ryan, Caitlin Eicher, Glenn Heller, Howard I. Scher
    The Journal of Urology December 2007 (Vol. 178, Issue 6, Pages 2378-2384)

The Journal of Urology
Volume 178, Issue 6 , Pages 2383-2384, December 2007

Article Tools